DALTEPARIN SODIUM

DALTEPARIN SODIUM was reported 10661 times

DALTEPARIN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 280 0.7235
1 ANTACID THERAPY 88 0.6769
2 SLEEP DISORDER THERAPY 115 0.5808
3 ANALGESIC THERAPY 128 0.3988
4 DRUG THERAPY 124 0.3658
5 LIVER IRON CONCENTRATION ABNORMAL 9 0.3600
6 ANTICOAGULANT THERAPY 89 0.3134
7 CONGENITAL HIATUS HERNIA 62 0.2719
8 VENOUS PRESSURE JUGULAR DECREASED 10 0.2632
9 MALIGNANT MELANOMA STAGE 0 54 0.2584
10 TRUNCUS ARTERIOSUS PERSISTENT 43 0.2161
11 BACTEROIDES INFECTION 37 0.1418
12 ARTERIOVENOUS FISTULA OCCLUSION 21 0.1200
13 LYMPH NODE CALCIFICATION 16 0.0825
14 HYPERPHOSPHATAEMIA 164 0.0762
15 VESSEL PUNCTURE SITE BRUISE 15 0.0754
16 GENITAL EROSION 22 0.0741
17 GRAFT VERSUS HOST DISEASE IN INTESTINE 9 0.0692
18 BLOOD PHOSPHORUS INCREASED 189 0.0692
19 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 58 0.0626
20 FOETAL CHROMOSOME ABNORMALITY 10 0.0588
21 BLUE TOE SYNDROME 22 0.0561
22 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 11 0.0489
23 CARDIAC SEPTAL DEFECT 35 0.0487
24 ABDOMINAL WALL HAEMORRHAGE 12 0.0460
25 CONGENITAL CARDIOVASCULAR ANOMALY 35 0.0417
26 OPERATIVE HAEMORRHAGE 18 0.0403
27 CARDIOMYOPATHY ACUTE 8 0.0365
28 HAEMANGIOMA CONGENITAL 15 0.0316
29 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 157 0.0310
30 APPENDICITIS 284 0.0304
31 TOTAL LUNG CAPACITY DECREASED 48 0.0300
32 BLADDER TAMPONADE 9 0.0297
33 DEVICE OPERATIONAL ISSUE 120 0.0279
34 BLOOD URIC ACID INCREASED 161 0.0279
35 SELECTIVE EATING DISORDER 25 0.0275
36 FOETAL HEART RATE DECELERATION ABNORMALITY 18 0.0255
37 IRON DEFICIENCY 112 0.0249
38 MUCOSAL EROSION 22 0.0242
39 AORTIC STENOSIS 83 0.0238
40 ENGRAFTMENT SYNDROME 14 0.0237
41 GASTRIC ANTRAL VASCULAR ECTASIA 12 0.0227
42 HYPOPHOSPHATAEMIA 166 0.0224
43 CONGESTIVE HEPATOPATHY 10 0.0223
44 PLEURITIC PAIN 60 0.0217
45 SPLENIC VEIN THROMBOSIS 11 0.0217
46 VENTRICULAR FIBRILLATION 240 0.0216
47 MYASTHENIA GRAVIS 173 0.0214
48 CARDIOGENIC SHOCK 304 0.0212
49 PLACENTAL INSUFFICIENCY 16 0.0199
50 HEPARIN-INDUCED THROMBOCYTOPENIA 98 0.0199
51 THROMBOCYTHAEMIA 11 0.0198
52 NEUTROPENIC INFECTION 18 0.0188
53 ANAL ATRESIA 10 0.0187
54 LUNG OPACITY 48 0.0182
55 ABDOMINAL WALL HAEMATOMA 33 0.0169
56 RESPIRATORY SYMPTOM 47 0.0165
57 ADRENAL HAEMORRHAGE 9 0.0161
58 INTERNAL FIXATION OF FRACTURE 9 0.0158
59 SUBCUTANEOUS HAEMATOMA 19 0.0149
60 INFECTIOUS PERITONITIS 10 0.0147
61 STREPTOCOCCAL BACTERAEMIA 16 0.0147
62 INTRA-ABDOMINAL HAEMATOMA 18 0.0145
63 TOXIC EPIDERMAL NECROLYSIS 200 0.0132
64 MULTIPLE ORGAN DYSFUNCTION SYNDROME 369 0.0130
65 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 12 0.0130
66 PROPOFOL INFUSION SYNDROME 9 0.0128
67 CARDIAC HYPERTROPHY 14 0.0126
68 HAEMOPERITONEUM 10 0.0125
69 RETROPERITONEAL HAEMORRHAGE 30 0.0121
70 BRONCHIAL OBSTRUCTION 17 0.0121
71 PITUITARY TUMOUR 18 0.0121
72 TROPONIN INCREASED 91 0.0119
73 BRADYCARDIA NEONATAL 15 0.0119
74 RETROPERITONEAL HAEMATOMA 26 0.0118
75 MUCOUS MEMBRANE DISORDER 16 0.0117
76 ASCITES 343 0.0117
77 HYDROCELE 12 0.0113
78 BENIGN PROSTATIC HYPERPLASIA 58 0.0112
79 BLOOD CALCIUM INCREASED 96 0.0109
80 CYTOMEGALOVIRUS TEST POSITIVE 19 0.0107
81 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 8 0.0104
82 BACTERIAL INFECTION 193 0.0103
83 HEART DISEASE CONGENITAL 36 0.0102
84 BREATH SOUNDS ABNORMAL 50 0.0101
85 CONTRAINDICATED PRODUCT PRESCRIBED 17 0.0101
86 HAEMORRHAGIC ANAEMIA 44 0.0100
87 BRONCHIAL DISORDER 15 0.0096
88 HYPOTHALAMO-PITUITARY DISORDER 14 0.0096
89 PLACENTAL DISORDER 9 0.0095
90 BLOOD CREATINE INCREASED 42 0.0095
91 NEEDLE ISSUE 275 0.0094
92 HYPERLIPIDAEMIA 111 0.0093
93 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 159 0.0093
94 INTRA-ABDOMINAL HAEMORRHAGE 21 0.0088
95 GESTATIONAL DIABETES 40 0.0084
96 AGITATION NEONATAL 8 0.0083
97 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 9 0.0083
98 PRODUCT MONITORING ERROR 12 0.0083
99 LOW BIRTH WEIGHT BABY 65 0.0082
100 COMPARTMENT SYNDROME 21 0.0080
101 HYPOGLYCAEMIA NEONATAL 13 0.0080
102 RESPIRATORY DISORDER NEONATAL 13 0.0080
103 BLOOD PRESSURE DIASTOLIC INCREASED 37 0.0080
104 ALVEOLITIS 11 0.0078
105 SURGICAL FAILURE 9 0.0078
106 OSTEOCHONDROSIS 9 0.0078
107 ULCER 123 0.0077
108 MUSCLE HAEMORRHAGE 31 0.0077
109 FEBRILE INFECTION 9 0.0076
110 DERMATITIS EXFOLIATIVE 38 0.0076
111 EXTRADURAL HAEMATOMA 10 0.0076
112 SMALL FOR DATES BABY 37 0.0074
113 THROMBOPHLEBITIS 26 0.0074
114 INTERNATIONAL NORMALISED RATIO DECREASED 30 0.0074
115 NEUTROPENIC SEPSIS 52 0.0073
116 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 9 0.0072
117 PHLEBITIS 37 0.0072
118 NEURALGIA 175 0.0072
119 TEMPERATURE REGULATION DISORDER 16 0.0072
120 LUNG CONSOLIDATION 20 0.0071
121 UPPER GASTROINTESTINAL HAEMORRHAGE 119 0.0071
122 PREMATURE RUPTURE OF MEMBRANES 17 0.0070
123 GOUT 126 0.0070
124 HAEMORRHAGE IN PREGNANCY 10 0.0070
125 BLOOD TEST ABNORMAL 98 0.0070
126 POST HERPETIC NEURALGIA 10 0.0070
127 BONE MARROW DISORDER 21 0.0069
128 LUNG CANCER METASTATIC 20 0.0069
129 VENTRICULAR SEPTAL DEFECT 39 0.0068
130 PORTAL VEIN THROMBOSIS 22 0.0068
131 CYTOMEGALOVIRUS VIRAEMIA 30 0.0067
132 METASTATIC MALIGNANT MELANOMA 15 0.0065
133 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 10 0.0065
134 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0065
135 PULMONARY EMBOLISM 618 0.0065
136 PREMATURE SEPARATION OF PLACENTA 10 0.0065
137 PERITONEAL HAEMORRHAGE 9 0.0065
138 OVARIAN HYPERSTIMULATION SYNDROME 15 0.0064
139 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 9 0.0064
140 END STAGE RENAL DISEASE 116 0.0064
141 HYPERCOAGULATION 12 0.0063
142 VENOUS THROMBOSIS LIMB 13 0.0063
143 LACUNAR INFARCTION 15 0.0063
144 HYPONATRAEMIA 353 0.0063
145 MEAN CELL VOLUME INCREASED 16 0.0062
146 BILIARY DILATATION 9 0.0061
147 ADENOCARCINOMA OF COLON 11 0.0059
148 BLOOD IRON INCREASED 11 0.0059
149 PURULENT DISCHARGE 25 0.0058
150 ASPIRATION 64 0.0058
151 SUBCUTANEOUS ABSCESS 28 0.0058
152 HYPERCHOLESTEROLAEMIA 56 0.0058
153 RASH MORBILLIFORM 16 0.0058
154 CLOSTRIDIUM DIFFICILE COLITIS 61 0.0057
155 ANTIPHOSPHOLIPID SYNDROME 9 0.0056
156 VENA CAVA THROMBOSIS 9 0.0054
157 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 9 0.0054
158 HISTIOCYTOSIS HAEMATOPHAGIC 16 0.0054
159 CHOLESTATIC LIVER INJURY 12 0.0054
160 WOUND SECRETION 21 0.0054
161 MATERNAL DRUGS AFFECTING FOETUS 41 0.0053
162 POST PROCEDURAL HAEMATOMA 9 0.0053
163 HEPATITIS CHOLESTATIC 32 0.0053
164 STAPHYLOCOCCAL SEPSIS 26 0.0053
165 VENOOCCLUSIVE LIVER DISEASE 26 0.0053
166 CAESAREAN SECTION 60 0.0051
167 KYPHOSIS 9 0.0051
168 MICTURITION URGENCY 58 0.0051
169 PRE-ECLAMPSIA 24 0.0050
170 SHOCK HAEMORRHAGIC 41 0.0050
171 SYRINGE ISSUE 88 0.0050
172 PULMONARY THROMBOSIS 54 0.0049
173 ELECTROLYTE IMBALANCE 56 0.0048
174 RED CELL DISTRIBUTION WIDTH INCREASED 20 0.0048
175 SKIN WARM 28 0.0048
176 HAEMOLYSIS 37 0.0048
177 FULL BLOOD COUNT ABNORMAL 50 0.0047
178 DEEP VEIN THROMBOSIS 307 0.0047
179 BRAIN HERNIATION 14 0.0047
180 BODY TEMPERATURE DECREASED 46 0.0047
181 EXPOSED BONE IN JAW 10 0.0046
182 SEPSIS 513 0.0046
183 MELAENA 101 0.0046
184 GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0045
185 FEBRILE NEUTROPENIA 298 0.0045
186 DISSEMINATED INTRAVASCULAR COAGULATION 63 0.0045
187 ABORTION 13 0.0045
188 HEPATOCELLULAR DAMAGE 10 0.0044
189 HYDRONEPHROSIS 33 0.0044
190 DUODENAL ULCER 31 0.0044
191 SUBDURAL HAEMORRHAGE 12 0.0044
192 READING DISORDER 10 0.0044
193 THROMBOSIS 351 0.0044
194 VARICES OESOPHAGEAL 13 0.0043
195 HAEMATOMA 111 0.0043
196 ENDOTRACHEAL INTUBATION 12 0.0043
197 DEVICE MATERIAL ISSUE 9 0.0043
198 PROTEIN TOTAL DECREASED 16 0.0042
199 PREMATURE LABOUR 24 0.0042
200 PULMONARY INFARCTION 10 0.0042
201 HAEMORRHAGIC DIATHESIS 15 0.0042
202 OESOPHAGITIS 46 0.0042
203 BLOOD PRESSURE DIASTOLIC DECREASED 31 0.0042
204 TRANSAMINASES INCREASED 93 0.0042
205 RALES 24 0.0041
206 GENERAL PHYSICAL HEALTH DETERIORATION 477 0.0041
207 ABDOMINAL MASS 11 0.0041
208 PREMATURE BABY 122 0.0040
209 LARGE INTESTINE PERFORATION 28 0.0040
210 CHOLECYSTITIS 48 0.0040
211 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 210 0.0040
212 LOWER RESPIRATORY TRACT INFECTION 179 0.0039
213 PERIPHERAL ISCHAEMIA 16 0.0039
214 CEREBRAL THROMBOSIS 11 0.0039
215 CHRONIC GRAFT VERSUS HOST DISEASE 14 0.0039
216 DUODENAL ULCER HAEMORRHAGE 11 0.0038
217 CLOSTRIDIAL INFECTION 13 0.0038
218 HAEMATEMESIS 97 0.0038
219 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
220 EXFOLIATIVE RASH 10 0.0038
221 COMA SCALE ABNORMAL 11 0.0038
222 NECROSIS 21 0.0038
223 CEREBRAL HAEMORRHAGE 135 0.0038
224 INTRACRANIAL PRESSURE INCREASED 21 0.0038
225 HYPOVOLAEMIA 22 0.0038
226 GAMMA-GLUTAMYLTRANSFERASE INCREASED 83 0.0037
227 EMBOLISM 31 0.0037
228 BLOOD CHOLESTEROL INCREASED 174 0.0037
229 ORGAN FAILURE 15 0.0037
230 BRONCHIECTASIS 25 0.0037
231 INCOHERENT 24 0.0037
232 CLONUS 10 0.0037
233 LOWER GASTROINTESTINAL HAEMORRHAGE 27 0.0036
234 TYPE IV HYPERSENSITIVITY REACTION 10 0.0036
235 ARTHROPOD BITE 27 0.0036
236 ILEUS PARALYTIC 16 0.0036
237 INTRACARDIAC THROMBUS 11 0.0036
238 DEVICE MECHANICAL ISSUE 49 0.0036
239 BLOOD CREATININE INCREASED 232 0.0035
240 APPENDICITIS PERFORATED 9 0.0035
241 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
242 BLOOD LOSS ANAEMIA 8 0.0035
243 ABORTION INDUCED 33 0.0035
244 AORTIC ARTERIOSCLEROSIS 9 0.0035
245 ABDOMINAL DISTENSION 365 0.0035
246 ACUTE GRAFT VERSUS HOST DISEASE 16 0.0035
247 EOSINOPHILIC PNEUMONIA 11 0.0035
248 HEPATITIS TOXIC 9 0.0035
249 DRUG LEVEL BELOW THERAPEUTIC 19 0.0034
250 JAUNDICE CHOLESTATIC 12 0.0034
251 THROMBOTIC MICROANGIOPATHY 33 0.0034
252 HYPERTHYROIDISM 49 0.0034
253 ERYSIPELAS 17 0.0034
254 HAEMORRHAGE SUBCUTANEOUS 12 0.0034
255 PLATELET COUNT INCREASED 44 0.0034
256 PLEURAL EFFUSION 204 0.0033
257 PROTHROMBIN TIME PROLONGED 20 0.0033
258 METABOLIC ENCEPHALOPATHY 10 0.0033
259 GANGRENE 20 0.0033
260 FEMORAL NECK FRACTURE 17 0.0033
261 DERMATITIS BULLOUS 24 0.0033
262 MYELOFIBROSIS 10 0.0033
263 THROMBOPHLEBITIS SUPERFICIAL 10 0.0033
264 APPLICATION SITE HAEMORRHAGE 9 0.0033
265 TRANSFUSION 34 0.0032
266 WOUND HAEMORRHAGE 12 0.0032
267 PORTAL HYPERTENSION 10 0.0032
268 GASTRITIS EROSIVE 15 0.0032
269 CATHETER SITE HAEMORRHAGE 8 0.0032
270 INTERNATIONAL NORMALISED RATIO INCREASED 90 0.0032
271 RESPIRATORY RATE INCREASED 28 0.0032
272 BLOOD ALBUMIN DECREASED 25 0.0031
273 BILE DUCT STONE 10 0.0031
274 HEMIPLEGIA 26 0.0031
275 MYOSITIS 28 0.0031
276 HUMERUS FRACTURE 15 0.0031
277 ESCHERICHIA SEPSIS 9 0.0031
278 HAEMOTHORAX 9 0.0031
279 POOR QUALITY DEVICE USED 31 0.0031
280 GRAFT VERSUS HOST DISEASE 22 0.0031
281 VENOUS THROMBOSIS 12 0.0031
282 RESPIRATORY ACIDOSIS 12 0.0030
283 GASTRIC ULCER 58 0.0030
284 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 10 0.0030
285 HAEMOLYTIC ANAEMIA 27 0.0030
286 MYOPATHY 26 0.0030
287 MUSCLE STRAIN 26 0.0030
288 DRUG EXPOSURE DURING PREGNANCY 102 0.0030
289 DEVICE OCCLUSION 42 0.0030
290 NEPHROGENIC SYSTEMIC FIBROSIS 9 0.0030
291 RENAL FAILURE ACUTE 126 0.0030
292 EMBOLISM VENOUS 9 0.0030
293 INGUINAL HERNIA 18 0.0030
294 DUODENITIS 9 0.0029
295 SUDDEN CARDIAC DEATH 10 0.0029
296 CEREBRAL ISCHAEMIA 15 0.0029
297 BLOOD LACTATE DEHYDROGENASE INCREASED 46 0.0029
298 AGRANULOCYTOSIS 53 0.0028
299 HAEMOGLOBIN DECREASED 291 0.0028
300 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 25 0.0028
301 ASPARTATE AMINOTRANSFERASE INCREASED 150 0.0028
302 JOINT INJURY 60 0.0028
303 BACTERAEMIA 33 0.0028
304 HEMIPARESIS 47 0.0028
305 HAEMATOCRIT DECREASED 55 0.0028
306 BLOOD ALKALINE PHOSPHATASE INCREASED 68 0.0027
307 BLOOD PHOSPHORUS DECREASED 10 0.0027
308 THROMBOCYTOSIS 10 0.0027
309 CYTOMEGALOVIRUS INFECTION REACTIVATION 12 0.0027
310 HYPERKALAEMIA 95 0.0027
311 HYPOALBUMINAEMIA 21 0.0027
312 OLIGOHYDRAMNIOS 9 0.0027
313 SWELLING 252 0.0027
314 HAEMOPTYSIS 75 0.0027
315 BLOOD CULTURE POSITIVE 8 0.0027
316 C-REACTIVE PROTEIN INCREASED 97 0.0027
317 MULTI-ORGAN FAILURE 46 0.0027
318 BRONCHOPNEUMONIA 9 0.0026
319 DIABETES MELLITUS 200 0.0026
320 WOUND COMPLICATION 9 0.0026
321 METASTASES TO BONE 43 0.0026
322 BLOOD PRESSURE SYSTOLIC INCREASED 51 0.0026
323 PETECHIAE 27 0.0026
324 PNEUMOTHORAX 41 0.0026
325 COAGULOPATHY 43 0.0026
326 RIGHT VENTRICULAR FAILURE 18 0.0026
327 SPINAL CORD COMPRESSION 10 0.0026
328 DRY MOUTH 208 0.0026
329 BLOOD CREATININE DECREASED 8 0.0026
330 THROMBOTIC THROMBOCYTOPENIC PURPURA 9 0.0026
331 PANCYTOPENIA 142 0.0025
332 RESPIRATORY DISORDER 76 0.0025
333 NEUTROPHIL COUNT INCREASED 26 0.0025
334 FIBRIN D DIMER INCREASED 9 0.0025
335 PATENT DUCTUS ARTERIOSUS 10 0.0025
336 THROMBOCYTOPENIA 281 0.0025
337 SLEEP DISORDER 177 0.0025
338 GASTROINTESTINAL TOXICITY 12 0.0025
339 CANDIDIASIS 10 0.0025
340 LUNG INFILTRATION 22 0.0025
341 HAEMATURIA 85 0.0025
342 CYSTITIS HAEMORRHAGIC 10 0.0025
343 MOUTH ULCERATION 52 0.0025
344 FOETAL GROWTH RESTRICTION 15 0.0025
345 BACTERIAL SEPSIS 8 0.0025
346 RENAL PAIN 26 0.0025
347 ANAL FISTULA 13 0.0024
348 SUSPECTED OFF LABEL USE 11 0.0024
349 HYPERURICAEMIA 10 0.0024
350 GASTROINTESTINAL HAEMORRHAGE 203 0.0024
351 LEG AMPUTATION 10 0.0024
352 COMPRESSION FRACTURE 13 0.0024
353 ENTEROCOLITIS 14 0.0024
354 POST PROCEDURAL HAEMORRHAGE 28 0.0024
355 ANAEMIA 458 0.0024
356 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
357 CYTOKINE RELEASE SYNDROME 48 0.0024
358 STEVENS-JOHNSON SYNDROME 53 0.0024
359 RASH MACULO-PAPULAR 53 0.0024
360 METASTASIS 17 0.0024
361 LIVER DISORDER 105 0.0024
362 MIOSIS 19 0.0024
363 HYPERTHERMIA 18 0.0024
364 MYOCLONUS 28 0.0023
365 HEPATIC LESION 10 0.0023
366 BLOOD CALCIUM DECREASED 26 0.0023
367 ABDOMINAL PAIN 537 0.0023
368 PULMONARY HAEMORRHAGE 18 0.0023
369 POST PROCEDURAL COMPLICATION 44 0.0023
370 DYSGRAPHIA 15 0.0023
371 ENTEROCOCCAL INFECTION 11 0.0023
372 IRON DEFICIENCY ANAEMIA 21 0.0023
373 ATRIAL SEPTAL DEFECT 19 0.0023
374 ALANINE AMINOTRANSFERASE INCREASED 139 0.0023
375 HAEMODIALYSIS 19 0.0023
376 SUBARACHNOID HAEMORRHAGE 23 0.0023
377 ATRIAL FLUTTER 18 0.0023
378 LIVER FUNCTION TEST INCREASED 48 0.0022
379 SPUTUM DISCOLOURED 21 0.0022
380 HAEMORRHAGE INTRACRANIAL 33 0.0022
381 VEIN DISORDER 11 0.0022
382 PNEUMOCYSTIS JIROVECII PNEUMONIA 22 0.0022
383 ECCHYMOSIS 15 0.0022
384 CORONARY ARTERY DISEASE 66 0.0022
385 HEPATIC FUNCTION ABNORMAL 81 0.0022
386 CEREBRAL INFARCTION 53 0.0022
387 LOCALISED OEDEMA 10 0.0022
388 NERVE INJURY 24 0.0022
389 CONJUNCTIVITIS 40 0.0022
390 MUCOSAL INFLAMMATION 56 0.0021
391 TRANSIENT ISCHAEMIC ATTACK 72 0.0021
392 CARDIOVASCULAR DISORDER 54 0.0021
393 SKIN NECROSIS 11 0.0021
394 METASTASES TO LIVER 37 0.0021
395 FOETAL EXPOSURE DURING PREGNANCY 171 0.0021
396 CYANOSIS 33 0.0021
397 CHOLANGITIS 13 0.0021
398 CONSTIPATION 457 0.0021
399 ACIDOSIS 16 0.0021
400 STAPHYLOCOCCAL BACTERAEMIA 9 0.0021
401 HYPERVENTILATION 12 0.0021
402 DRUG INTERACTION 325 0.0020
403 ORAL DISORDER 15 0.0020
404 SECOND PRIMARY MALIGNANCY 17 0.0020
405 FLANK PAIN 19 0.0020
406 SUBDURAL HAEMATOMA 29 0.0020
407 WOUND INFECTION 22 0.0020
408 CEREBRAL ATROPHY 8 0.0020
409 DELIRIUM 69 0.0020
410 INTENTIONAL PRODUCT MISUSE 174 0.0020
411 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
412 HYPOKALAEMIA 91 0.0020
413 PULMONARY ALVEOLAR HAEMORRHAGE 11 0.0020
414 CANDIDA INFECTION 33 0.0020
415 OEDEMA PERIPHERAL 238 0.0020
416 CARDIAC FAILURE ACUTE 13 0.0019
417 CIRCULATORY COLLAPSE 33 0.0019
418 DRUG INTOLERANCE 187 0.0019
419 HYPERBILIRUBINAEMIA 20 0.0019
420 APLASTIC ANAEMIA 10 0.0019
421 PARTIAL SEIZURES 10 0.0019
422 METASTASES TO LUNG 22 0.0019
423 DEVICE DEFECTIVE 33 0.0019
424 JAUNDICE 51 0.0019
425 ABSCESS LIMB 8 0.0019
426 MALNUTRITION 21 0.0019
427 EPISTAXIS 140 0.0019
428 HEPATIC FAILURE 56 0.0019
429 BLOOD BILIRUBIN INCREASED 50 0.0018
430 ORTHOSTATIC HYPOTENSION 32 0.0018
431 PALLOR 50 0.0018
432 POOR VENOUS ACCESS 19 0.0018
433 HYDROCEPHALUS 10 0.0018
434 BLISTER 103 0.0018
435 PREMATURE DELIVERY 29 0.0018
436 SPINAL OSTEOARTHRITIS 16 0.0018
437 BRAIN OEDEMA 23 0.0018
438 TUMOUR LYSIS SYNDROME 16 0.0018
439 INFLAMMATORY MARKER INCREASED 9 0.0018
440 SPINAL COMPRESSION FRACTURE 15 0.0018
441 LYMPHOCYTE COUNT DECREASED 32 0.0018
442 ABDOMINAL ABSCESS 8 0.0018
443 STREPTOCOCCAL INFECTION 10 0.0018
444 RESPIRATORY DEPRESSION 22 0.0018
445 NEUTROPHIL COUNT DECREASED 73 0.0018
446 HYPOXIA 63 0.0018
447 PERITONITIS 37 0.0018
448 TOXIC ENCEPHALOPATHY 9 0.0018
449 PATHOLOGICAL FRACTURE 9 0.0018
450 OLIGURIA 11 0.0018
451 TUBULOINTERSTITIAL NEPHRITIS 33 0.0018
452 ACUTE KIDNEY INJURY 269 0.0018
453 SECRETION DISCHARGE 22 0.0018
454 ABDOMINAL HERNIA 8 0.0018
455 CACHEXIA 9 0.0017
456 PULMONARY MASS 26 0.0017
457 TRISMUS 9 0.0017
458 ANURIA 15 0.0017
459 PLATELET COUNT DECREASED 184 0.0017
460 BONE MARROW FAILURE 35 0.0017
461 LIVER FUNCTION TEST ABNORMAL 50 0.0017
462 HEPATIC ENCEPHALOPATHY 16 0.0017
463 GASTRITIS 45 0.0017
464 SPINAL PAIN 20 0.0017
465 LUNG DISORDER 83 0.0017
466 HAEMORRHAGE 177 0.0017
467 RENAL FAILURE CHRONIC 13 0.0017
468 ACUTE CORONARY SYNDROME 14 0.0017
469 EOSINOPHIL COUNT INCREASED 14 0.0017
470 RED BLOOD CELL COUNT DECREASED 48 0.0017
471 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
472 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
473 APNOEA 13 0.0017
474 RESTLESSNESS 61 0.0017
475 TORSADE DE POINTES 13 0.0017
476 DEVICE DEPLOYMENT ISSUE 21 0.0016
477 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 42 0.0016
478 METASTASES TO LYMPH NODES 11 0.0016
479 METASTASES TO CENTRAL NERVOUS SYSTEM 21 0.0016
480 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
481 EXPOSURE DURING PREGNANCY 101 0.0016
482 BLOOD MAGNESIUM DECREASED 14 0.0016
483 DEHYDRATION 216 0.0016
484 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
485 BODY TEMPERATURE INCREASED 33 0.0016
486 PULMONARY FIBROSIS 31 0.0016
487 ILEUS 20 0.0016
488 SUDDEN DEATH 17 0.0016
489 DIARRHOEA HAEMORRHAGIC 15 0.0016
490 RESPIRATORY FAILURE 117 0.0016
491 MATERNAL EXPOSURE DURING PREGNANCY 143 0.0016
492 HYPOTONIA 16 0.0016
493 NEUROLEPTIC MALIGNANT SYNDROME 19 0.0016
494 ENCEPHALITIS 11 0.0016
495 SOMNOLENCE 320 0.0016
496 HAEMODYNAMIC INSTABILITY 12 0.0016
497 HYPERTONIA 9 0.0016
498 MYOCARDITIS 18 0.0016
499 UPPER RESPIRATORY TRACT INFECTION 72 0.0016
500 RESPIRATORY DISTRESS 43 0.0016
501 CHOLELITHIASIS 51 0.0016
502 BLOOD UREA INCREASED 26 0.0016
503 ATELECTASIS 15 0.0016
504 CONTRAINDICATED PRODUCT ADMINISTERED 47 0.0016
505 TACHYPNOEA 21 0.0015
506 DEPRESSED LEVEL OF CONSCIOUSNESS 61 0.0015
507 HEPATITIS ACUTE 10 0.0015
508 HAEMORRHAGIC STROKE 12 0.0015
509 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
510 SHOCK 35 0.0015
511 UROSEPSIS 14 0.0015
512 RECTAL HAEMORRHAGE 65 0.0015
513 ABSCESS 24 0.0015
514 ACUTE MYOCARDIAL INFARCTION 44 0.0015
515 URINE OUTPUT DECREASED 13 0.0015
516 EMPHYSEMA 15 0.0015
517 LEUKOPENIA 74 0.0015
518 OXYGEN SATURATION DECREASED 83 0.0015
519 SEPTIC SHOCK 64 0.0015
520 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
521 SMALL INTESTINAL OBSTRUCTION 18 0.0015
522 HICCUPS 12 0.0015
523 HYPERCALCAEMIA 18 0.0015
524 PYREXIA 501 0.0014
525 INFUSION SITE EXTRAVASATION 9 0.0014
526 FLUID OVERLOAD 21 0.0014
527 AUTOIMMUNE HEPATITIS 10 0.0014
528 BLOOD IRON DECREASED 17 0.0014
529 DEVICE RELATED INFECTION 22 0.0014
530 NEUTROPENIA 194 0.0014
531 MALIGNANT NEOPLASM PROGRESSION 145 0.0014
532 INCREASED TENDENCY TO BRUISE 13 0.0014
533 CARDIAC VALVE DISEASE 8 0.0014
534 DRUG LEVEL INCREASED 23 0.0014
535 CELLULITIS 70 0.0014
536 CARDIOMEGALY 17 0.0014
537 CONDITION AGGRAVATED 418 0.0014
538 ORAL CANDIDIASIS 18 0.0014
539 PULMONARY CONGESTION 18 0.0014
540 PULMONARY OEDEMA 61 0.0014
541 TACHYCARDIA 121 0.0014
542 MEDICAL DEVICE COMPLICATION 10 0.0014
543 SINUS BRADYCARDIA 13 0.0013
544 ISCHAEMIC STROKE 24 0.0013
545 POLYURIA 11 0.0013
546 BREAST MASS 9 0.0013
547 POSTOPERATIVE WOUND INFECTION 9 0.0013
548 NEOPLASM PROGRESSION 46 0.0013
549 HYPOCALCAEMIA 25 0.0013
550 PRODUCTIVE COUGH 63 0.0013
551 COLITIS 50 0.0013
552 NEPHROTIC SYNDROME 9 0.0013
553 CARDIAC FAILURE 105 0.0013
554 DEVICE PHYSICAL PROPERTY ISSUE 10 0.0013
555 CHOLESTASIS 25 0.0013
556 PERICARDIAL EFFUSION 30 0.0013
557 BLOOD PRESSURE DECREASED 85 0.0013
558 HEPATIC CIRRHOSIS 24 0.0013
559 WHITE BLOOD CELL COUNT INCREASED 49 0.0013
560 SKIN LESION 35 0.0013
561 OEDEMA 69 0.0013
562 DIPLOPIA 33 0.0013
563 CONFUSIONAL STATE 205 0.0013
564 TRICUSPID VALVE INCOMPETENCE 10 0.0013
565 NAIL DISORDER 11 0.0013
566 VOMITING 586 0.0012
567 FAECES DISCOLOURED 27 0.0012
568 MITRAL VALVE INCOMPETENCE 14 0.0012
569 MUSCULOSKELETAL STIFFNESS 108 0.0012
570 ATRIAL FIBRILLATION 120 0.0012
571 MOUTH HAEMORRHAGE 9 0.0012
572 HYPOMAGNESAEMIA 17 0.0012
573 CARDIOMYOPATHY 18 0.0012
574 PNEUMONITIS 33 0.0012
575 DRUG-INDUCED LIVER INJURY 38 0.0012
576 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
577 VASCULITIS 14 0.0012
578 PNEUMONIA 389 0.0012
579 RHABDOMYOLYSIS 50 0.0012
580 HAEMATOCHEZIA 66 0.0012
581 DYSPNOEA EXERTIONAL 45 0.0012
582 COLITIS ISCHAEMIC 8 0.0012
583 NERVOUS SYSTEM DISORDER 37 0.0012
584 ERYTHEMA MULTIFORME 11 0.0012
585 DRUG LEVEL DECREASED 12 0.0012
586 RED BLOOD CELL SEDIMENTATION RATE INCREASED 13 0.0012
587 FACIAL PARALYSIS 10 0.0012
588 INJECTION SITE HAEMATOMA 17 0.0012
589 DIFFUSE LARGE B-CELL LYMPHOMA 9 0.0012
590 APHASIA 35 0.0012
591 LUNG INFECTION 18 0.0012
592 HIATUS HERNIA 15 0.0012
593 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
594 PULMONARY HYPERTENSION 24 0.0012
595 HYPERTENSION 243 0.0011
596 WEIGHT FLUCTUATION 12 0.0011
597 CYTOMEGALOVIRUS INFECTION 19 0.0011
598 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
599 PURPURA 10 0.0011
600 RENAL FAILURE 150 0.0011
601 SINUS TACHYCARDIA 16 0.0011
602 RENAL TUBULAR NECROSIS 11 0.0011
603 PNEUMONIA ASPIRATION 28 0.0011
604 THERAPY CHANGE 11 0.0011
605 BLOOD URINE PRESENT 21 0.0011
606 SPINAL FRACTURE 22 0.0011
607 ACUTE HEPATIC FAILURE 15 0.0011
608 PANCREATITIS 58 0.0011
609 ATAXIA 13 0.0011
610 RENAL IMPAIRMENT 92 0.0011
611 ESCHERICHIA INFECTION 9 0.0011
612 PERIPHERAL COLDNESS 15 0.0011
613 ACUTE RESPIRATORY FAILURE 21 0.0011
614 VENTRICULAR TACHYCARDIA 18 0.0011
615 PRESCRIBED OVERDOSE 21 0.0011
616 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
617 CARDIAC ARREST 89 0.0011
618 HYPOTENSION 216 0.0011
619 LYMPHADENOPATHY 38 0.0011
620 HYPERGLYCAEMIA 39 0.0011
621 ABDOMINAL PAIN LOWER 27 0.0011
622 LIMB INJURY 29 0.0011
623 DYSPNOEA 603 0.0011
624 HEART RATE IRREGULAR 24 0.0011
625 STAPHYLOCOCCAL INFECTION 35 0.0011
626 BLOOD SODIUM DECREASED 20 0.0011
627 DEVICE DELIVERY SYSTEM ISSUE 29 0.0011
628 ENCEPHALOPATHY 26 0.0011
629 HEPATOCELLULAR INJURY 15 0.0011
630 STOMATITIS 64 0.0011
631 ANAPHYLACTIC REACTION 58 0.0010
632 PSEUDOMONAS INFECTION 9 0.0010
633 CONTUSION 101 0.0010
634 DISEASE PROGRESSION 124 0.0010
635 LETHARGY 60 0.0010
636 MUSCULOSKELETAL CHEST PAIN 16 0.0010
637 CONGENITAL ANOMALY 8 0.0010
638 FEMUR FRACTURE 32 0.0010
639 INJURY ASSOCIATED WITH DEVICE 21 0.0010
640 HEART RATE INCREASED 102 0.0010
641 VITAMIN D DEFICIENCY 10 0.0010
642 GROIN PAIN 9 0.0010
643 CHROMATURIA 23 0.0010
644 DRUG ERUPTION 18 0.0010
645 HYPOGLYCAEMIA 49 0.0010
646 UNRESPONSIVE TO STIMULI 26 0.0010
647 BLADDER DISORDER 10 0.0010
648 POLYNEUROPATHY 12 0.0010
649 GASTROINTESTINAL PAIN 11 0.0010
650 SENSORY DISTURBANCE 16 0.0010
651 LYMPHOPENIA 14 0.0010
652 SEROTONIN SYNDROME 19 0.0010
653 ADRENAL INSUFFICIENCY 12 0.0010
654 BLOOD POTASSIUM INCREASED 16 0.0010
655 SKIN INFECTION 11 0.0010
656 HYPOPHAGIA 25 0.0010
657 ELECTROCARDIOGRAM QT PROLONGED 35 0.0010
658 ERYTHEMA 199 0.0010
659 EJECTION FRACTION DECREASED 15 0.0010
660 THERAPY PARTIAL RESPONDER 15 0.0010
661 ARTERIOSCLEROSIS 9 0.0010
662 GASTRIC HAEMORRHAGE 11 0.0010
663 PREGNANCY 19 0.0009
664 FEELING COLD 26 0.0009
665 NIGHT SWEATS 30 0.0009
666 DEVICE ISSUE 83 0.0009
667 HAEMORRHOIDS 18 0.0009
668 RASH PRURITIC 50 0.0009
669 WHITE BLOOD CELL COUNT DECREASED 100 0.0009
670 BLOOD PRESSURE FLUCTUATION 22 0.0009
671 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
672 DIALYSIS 13 0.0009
673 DIABETIC KETOACIDOSIS 22 0.0009
674 HEPATIC STEATOSIS 17 0.0009
675 HEART RATE DECREASED 32 0.0009
676 NAUSEA 720 0.0009
677 METABOLIC ACIDOSIS 29 0.0009
678 COMA 43 0.0009
679 HEPATITIS 23 0.0009
680 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
681 URINARY TRACT INFECTION 153 0.0009
682 INTESTINAL PERFORATION 10 0.0009
683 GASTROENTERITIS 13 0.0009
684 TOOTH ABSCESS 9 0.0009
685 MOTOR DYSFUNCTION 9 0.0009
686 GASTROINTESTINAL DISORDER 79 0.0009
687 INFECTION 127 0.0009
688 SCAB 10 0.0009
689 ABORTION SPONTANEOUS 35 0.0009
690 TENDERNESS 9 0.0009
691 HEPATIC CYTOLYSIS 11 0.0009
692 CARDIO-RESPIRATORY ARREST 36 0.0009
693 RASH MACULAR 30 0.0009
694 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20 0.0009
695 EOSINOPHILIA 15 0.0009
696 SPLENOMEGALY 10 0.0009
697 SKIN REACTION 12 0.0009
698 INCONTINENCE 9 0.0009
699 EPILEPSY 26 0.0008
700 INFUSION RELATED REACTION 56 0.0008
701 CHEST PAIN 156 0.0008
702 LOWER LIMB FRACTURE 16 0.0008
703 BLOOD POTASSIUM DECREASED 25 0.0008
704 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
705 LEUKOCYTOSIS 15 0.0008
706 INTERSTITIAL LUNG DISEASE 40 0.0008
707 HEPATIC ENZYME INCREASED 56 0.0008
708 JOINT RANGE OF MOTION DECREASED 11 0.0008
709 TREMOR 136 0.0008
710 BLOOD PRESSURE INCREASED 125 0.0008
711 CYSTITIS 26 0.0008
712 OFF LABEL USE 714 0.0008
713 URINARY RETENTION 27 0.0008
714 DRUG TOXICITY 11 0.0008
715 OSTEOPOROSIS 33 0.0008
716 MUSCULAR WEAKNESS 91 0.0008
717 SYNCOPE 80 0.0008
718 PRODUCT USE IN UNAPPROVED INDICATION 198 0.0008
719 BRAIN INJURY 8 0.0008
720 STATUS EPILEPTICUS 9 0.0008
721 INFLAMMATION 41 0.0008
722 COLD SWEAT 14 0.0008
723 ASTHMA 89 0.0008
724 MASS 11 0.0008
725 GASTROOESOPHAGEAL REFLUX DISEASE 63 0.0008
726 PERIPHERAL SWELLING 120 0.0008
727 ANAPHYLACTIC SHOCK 20 0.0008
728 RASH GENERALISED 20 0.0008
729 FACE OEDEMA 13 0.0008
730 OSTEONECROSIS OF JAW 19 0.0008
731 OROPHARYNGEAL PAIN 71 0.0008
732 FEELING HOT 47 0.0008
733 INJECTION SITE HAEMORRHAGE 61 0.0008
734 RESPIRATORY ARREST 21 0.0008
735 ORAL PAIN 17 0.0008
736 RHINORRHOEA 49 0.0008
737 FALL 251 0.0008
738 COGNITIVE DISORDER 35 0.0007
739 BREAST CANCER METASTATIC 8 0.0007
740 WEIGHT DECREASED 207 0.0007
741 LACTIC ACIDOSIS 24 0.0007
742 PRESYNCOPE 18 0.0007
743 TASTE DISORDER 15 0.0007
744 NO THERAPEUTIC RESPONSE 9 0.0007
745 CONVULSION 42 0.0007
746 ANGINA PECTORIS 21 0.0007
747 DECREASED APPETITE 169 0.0007
748 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
749 HIP FRACTURE 23 0.0007
750 DIARRHOEA 461 0.0007
751 PANCREATITIS ACUTE 16 0.0007
752 ASTHENIA 267 0.0007
753 URINARY INCONTINENCE 21 0.0007
754 COUGH 198 0.0007
755 PARALYSIS 10 0.0007
756 PLASMA CELL MYELOMA 27 0.0007
757 MYELODYSPLASTIC SYNDROME 10 0.0007
758 DYSARTHRIA 26 0.0007
759 INTENTIONAL PRODUCT USE ISSUE 60 0.0007
760 CEREBROVASCULAR ACCIDENT 116 0.0007
761 BEDRIDDEN 9 0.0007
762 BACK PAIN 159 0.0007
763 OSTEOARTHRITIS 29 0.0007
764 PROTEINURIA 13 0.0007
765 RIB FRACTURE 14 0.0007
766 LOSS OF CONSCIOUSNESS 87 0.0007
767 THERAPY NON-RESPONDER 30 0.0007
768 DRUG DOSE OMISSION BY DEVICE 52 0.0007
769 INTESTINAL OBSTRUCTION 25 0.0007
770 GINGIVAL BLEEDING 9 0.0007
771 CHILLS 77 0.0007
772 SKIN DISCOLOURATION 30 0.0007
773 RESPIRATORY TRACT INFECTION 17 0.0007
774 INCORRECT DOSE ADMINISTERED BY DEVICE 17 0.0006
775 LYMPHOMA 10 0.0006
776 ANKLE FRACTURE 10 0.0006
777 NASOPHARYNGITIS 119 0.0006
778 DYSPHAGIA 61 0.0006
779 FEEDING DISORDER 13 0.0006
780 WHEEZING 38 0.0006
781 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
782 MUSCULOSKELETAL DISCOMFORT 11 0.0006
783 FRACTURE 12 0.0006
784 IMPAIRED QUALITY OF LIFE 9 0.0006
785 PANCREATIC CARCINOMA 18 0.0006
786 VAGINAL HAEMORRHAGE 27 0.0006
787 PAIN 379 0.0006
788 LIMB DISCOMFORT 19 0.0006
789 LIVER INJURY 15 0.0006
790 MUSCULOSKELETAL PAIN 32 0.0006
791 DISEASE RECURRENCE 29 0.0006
792 WOUND 17 0.0006
793 BRONCHITIS 45 0.0006
794 PAIN IN EXTREMITY 179 0.0006
795 PELVIC PAIN 11 0.0006
796 RESTLESS LEGS SYNDROME 11 0.0006
797 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 109 0.0006
798 COLITIS ULCERATIVE 27 0.0006
799 DEVICE LEAKAGE 26 0.0006
800 JOINT SWELLING 72 0.0006
801 FREQUENT BOWEL MOVEMENTS 16 0.0006
802 FATIGUE 461 0.0006
803 CATARACT 35 0.0006
804 BRADYCARDIA 31 0.0006
805 SKIN ULCER 15 0.0006
806 RASH PAPULAR 13 0.0006
807 LOCALISED INFECTION 14 0.0006
808 BASAL CELL CARCINOMA 9 0.0006
809 WITHDRAWAL SYNDROME 24 0.0006
810 HALLUCINATION, VISUAL 12 0.0006
811 HYPERHIDROSIS 73 0.0006
812 ANGIOEDEMA 25 0.0006
813 WEIGHT INCREASED 126 0.0006
814 VERTIGO 34 0.0006
815 DISTURBANCE IN ATTENTION 30 0.0006
816 NECK PAIN 31 0.0006
817 INJECTION SITE RASH 17 0.0006
818 SEIZURE 64 0.0006
819 ABDOMINAL PAIN UPPER 114 0.0006
820 IMPAIRED HEALING 18 0.0005
821 PARAESTHESIA 85 0.0005
822 MEDICATION ERROR 30 0.0005
823 HEPATOTOXICITY 12 0.0005
824 HEAD INJURY 17 0.0005
825 HYPOTHYROIDISM 17 0.0005
826 BLOOD COUNT ABNORMAL 8 0.0005
827 MUSCLE TWITCHING 12 0.0005
828 DYSPEPSIA 51 0.0005
829 ECZEMA 27 0.0005
830 LOCAL SWELLING 9 0.0005
831 INJECTION SITE MASS 19 0.0005
832 KIDNEY INFECTION 10 0.0005
833 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
834 BLOOD PRESSURE ABNORMAL 10 0.0005
835 PRESCRIBED UNDERDOSE 10 0.0005
836 DEATH 422 0.0005
837 HERPES ZOSTER 28 0.0005
838 LUNG NEOPLASM MALIGNANT 20 0.0005
839 RASH 212 0.0005
840 LIP SWELLING 16 0.0005
841 DISORIENTATION 19 0.0005
842 INJECTION SITE BRUISING 38 0.0005
843 SLEEP APNOEA SYNDROME 9 0.0005
844 EATING DISORDER 10 0.0005
845 DIVERTICULITIS 13 0.0005
846 MENTAL STATUS CHANGES 13 0.0005
847 WRONG TECHNIQUE IN DRUG USAGE PROCESS 17 0.0005
848 IMPAIRED WORK ABILITY 10 0.0005
849 MOVEMENT DISORDER 15 0.0005
850 DEMENTIA 13 0.0005
851 NEOPLASM MALIGNANT 31 0.0005
852 CHOKING 9 0.0005
853 ORAL HERPES 9 0.0005
854 HYPERSENSITIVITY 85 0.0005
855 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
856 NEUROPATHY PERIPHERAL 43 0.0005
857 RENAL DISORDER 21 0.0005
858 HEADACHE 282 0.0004
859 MALAISE 197 0.0004
860 MYOCARDIAL INFARCTION 78 0.0004
861 PRODUCT ADMINISTRATION ERROR 9 0.0004
862 ABASIA 11 0.0004
863 PSYCHOTIC DISORDER 13 0.0004
864 BONE DISORDER 8 0.0004
865 SPEECH DISORDER 23 0.0004
866 HALLUCINATION 33 0.0004
867 NEPHROLITHIASIS 20 0.0004
868 ARTHRITIS 34 0.0004
869 DERMATITIS 9 0.0004
870 DEVICE DIFFICULT TO USE 28 0.0004
871 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
872 CHEST DISCOMFORT 43 0.0004
873 JOINT STIFFNESS 11 0.0004
874 DEVICE BREAKAGE 17 0.0004
875 RASH ERYTHEMATOUS 20 0.0004
876 DYSKINESIA 17 0.0004
877 PRURITUS GENERALISED 9 0.0004
878 AMNESIA 27 0.0004
879 FLUID RETENTION 21 0.0004
880 DYSSTASIA 12 0.0004
881 PALPITATIONS 48 0.0004
882 AGITATION 30 0.0004
883 FLUSHING 41 0.0004
884 ARRHYTHMIA 19 0.0004
885 TOXICITY TO VARIOUS AGENTS 67 0.0004
886 PROCEDURAL PAIN 11 0.0004
887 SKIN DISORDER 13 0.0004
888 MOBILITY DECREASED 28 0.0004
889 PRODUCT USE ISSUE 73 0.0004
890 HYPOAESTHESIA 58 0.0004
891 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
892 HYPERSOMNIA 11 0.0004
893 BALANCE DISORDER 33 0.0004
894 PRODUCT PRESCRIBING ERROR 9 0.0004
895 BLOOD GLUCOSE DECREASED 18 0.0004
896 PRURITUS 142 0.0004
897 INJECTION SITE URTICARIA 9 0.0004
898 URTICARIA 61 0.0004
899 CARDIAC FAILURE CONGESTIVE 29 0.0004
900 DIZZINESS 180 0.0004
901 PRODUCT DOSE OMISSION ISSUE 106 0.0004
902 GAIT INABILITY 12 0.0004
903 DRUG ADMINISTRATION ERROR 11 0.0004
904 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
905 DYSURIA 13 0.0004
906 MYALGIA 60 0.0004
907 SWOLLEN TONGUE 11 0.0004
908 INJECTION SITE PAIN 108 0.0004
909 ILLNESS 36 0.0003
910 HOT FLUSH 26 0.0003
911 SEDATION 9 0.0003
912 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
913 SWELLING FACE 22 0.0003
914 GAIT DISTURBANCE 64 0.0003
915 THROAT TIGHTNESS 9 0.0003
916 INFLUENZA 37 0.0003
917 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
918 LACRIMATION INCREASED 10 0.0003
919 FUNGAL INFECTION 11 0.0003
920 ARTHRALGIA 135 0.0003
921 BONE PAIN 19 0.0003
922 INSOMNIA 86 0.0003
923 MENTAL DISORDER 14 0.0003
924 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
925 MEMORY IMPAIRMENT 44 0.0003
926 COVID-19 53 0.0003
927 VISUAL ACUITY REDUCED 10 0.0003
928 BURNING SENSATION 21 0.0003
929 VISUAL IMPAIRMENT 37 0.0003
930 INJECTION SITE PRURITUS 20 0.0003
931 TYPE 2 DIABETES MELLITUS 10 0.0003
932 DYSGEUSIA 22 0.0003
933 EYE SWELLING 11 0.0003
934 BLINDNESS 12 0.0003
935 DRY SKIN 39 0.0003
936 ROAD TRAFFIC ACCIDENT 12 0.0003
937 TINNITUS 13 0.0003
938 CHRONIC KIDNEY DISEASE 21 0.0003
939 PANIC ATTACK 10 0.0003
940 OSTEONECROSIS 9 0.0003
941 RHEUMATOID ARTHRITIS 31 0.0003
942 SKIN EXFOLIATION 23 0.0003
943 VISION BLURRED 36 0.0003
944 INJECTION SITE REACTION 18 0.0003
945 INCORRECT DOSE ADMINISTERED 59 0.0003
946 CARDIAC DISORDER 24 0.0003
947 ABDOMINAL DISCOMFORT 43 0.0003
948 DRUG INEFFECTIVE 332 0.0003
949 ANXIETY 71 0.0002
950 NERVOUSNESS 13 0.0002
951 FLATULENCE 14 0.0002
952 ALOPECIA 48 0.0002
953 INJURY 17 0.0002
954 DYSPHONIA 14 0.0002
955 BLOOD GLUCOSE INCREASED 45 0.0002
956 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
957 INJECTION SITE SWELLING 18 0.0002
958 HYPOACUSIS 10 0.0002
959 INFLUENZA LIKE ILLNESS 19 0.0002
960 COLORECTAL CANCER 11 0.0002
961 SUICIDAL IDEATION 21 0.0002
962 OVERDOSE 49 0.0002
963 MUSCLE SPASMS 41 0.0002
964 NASAL CONGESTION 13 0.0002
965 DRY EYE 11 0.0002
966 ACCIDENTAL OVERDOSE 8 0.0002
967 TREATMENT FAILURE 18 0.0002
968 IRRITABILITY 13 0.0002
969 HOSPITALISATION 33 0.0002
970 SINUSITIS 22 0.0002
971 INJECTION SITE ERYTHEMA 25 0.0002
972 DEVICE MALFUNCTION 14 0.0002
973 UNEVALUABLE EVENT 15 0.0002
974 SUICIDE ATTEMPT 12 0.0002
975 ARTHROPATHY 11 0.0002
976 DEPRESSION 43 0.0002
977 MIGRAINE 18 0.0002
978 SURGERY 11 0.0002
979 DRUG EFFECT DECREASED 10 0.0002
980 FEELING ABNORMAL 43 0.0002
981 UNDERDOSE 13 0.0002
982 INTENTIONAL OVERDOSE 11 0.0002
983 BLADDER CANCER 10 0.0002
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
985 PRODUCT QUALITY ISSUE 21 0.0002
986 SKIN BURNING SENSATION 11 0.0002
987 THERAPEUTIC RESPONSE DECREASED 9 0.0001
988 DISCOMFORT 9 0.0001
989 ADVERSE DRUG REACTION 12 0.0001
990 PROSTATE CANCER 10 0.0001
991 ADVERSE EVENT 11 0.0001
992 BREAST CANCER 11 0.0001
993 EMOTIONAL DISTRESS 11 0.0001
994 NO ADVERSE EVENT 16 0.0001
995 DRUG DOSE OMISSION 11 0.0001